Lasalocid

This classification denotes an antibiotic with the molecular formula C34H54O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W7V2ZZ2FWB, chemically known as 2,3-cresotic acid, 6-(7-(5-ethyl-5-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyra but more generally known as lasalocid, which bears US NIH Compound Identifier 3888. European Medicines Agency schedules Lasalocid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08406MIG. The term LASALOCID is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 28, No. 10 1974, List 14). LASALOCID is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lasalocid under HS 29419000 and SITC 54139. As of Q4 2014, LASALOCID remains the US FDA Preferred Term for this commodity. Lasalocid bears US NLM identifiers UMLS ID C0023082 and NCI Concept Code C79131. SMILES: O1C(CC(C1C(CC)C(=O)C(C(O)C(CCC1C(C(O)C(CC1)C)C(=O)O)C)C)C)(C1OC(C(O)(CC1)CC)C)CC.